NCT01009528

Brief Summary

The aim of this study is to determine whether electronic feedback to general practitioners on quality of Type 2-Diabetes care increases the quality of care measured on process and outcome measures contained in the national guidelines. Effect evaluation will be performed using a mixed method design.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,458

participants targeted

Target at P75+ for not_applicable type-2-diabetes

Timeline
Completed

Started Mar 2007

Typical duration for not_applicable type-2-diabetes

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2007

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2008

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2009

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

November 5, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 6, 2009

Completed
Last Updated

November 9, 2009

Status Verified

November 1, 2009

Enrollment Period

1.3 years

First QC Date

November 5, 2009

Last Update Submit

November 6, 2009

Conditions

Keywords

Quality of careGeneral PracticeElectronic Feedback System

Outcome Measures

Primary Outcomes (1)

  • Outcome and process measures from the danish diabetes guideline

    1/3 2007-1/6 2008

Secondary Outcomes (1)

  • Interview data concerning the impact of the electronic feedback system in the intervention clinics

    1/3 2007-1/6 2008

Study Arms (2)

Intervention

EXPERIMENTAL

Admission to electronic feedback system

Device: Electronic feedback system on diabetes care

control

NO INTERVENTION

Control group. No special attention

Interventions

An electronic feedback system was introduced in randomized primary care clinics providing an overview of quality of care. The intervention ran for 15 months.

Also known as: Electronic feedback system, Decission support system
Intervention

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Prevalent Type 2-diabetes as confirmed by Primary Care Physician.
  • Patient alive throughout the intervention period.
  • GP actively working throughout the intervention period (not retired).

You may not qualify if:

  • death during intervention
  • moved out of geographic area during intervention
  • GP retired during intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dept. of General Medicine, Institute of Public Health, Aarhus University

Aarhus, 8000, Denmark

Location

Related Publications (3)

  • Guldberg TL, Lauritzen T, Kristensen JK, Vedsted P. The effect of feedback to general practitioners on quality of care for people with type 2 diabetes. A systematic review of the literature. BMC Fam Pract. 2009 May 6;10:30. doi: 10.1186/1471-2296-10-30.

    PMID: 19419548BACKGROUND
  • Guldberg TL, Vedsted P, Kristensen JK, Lauritzen T. Improved quality of Type 2 diabetes care following electronic feedback of treatment status to general practitioners: a cluster randomized controlled trial. Diabet Med. 2011 Mar;28(3):325-32. doi: 10.1111/j.1464-5491.2010.03178.x.

  • Guldberg TL, Vedsted P, Lauritzen T, Zoffmann V. Suboptimal quality of type 2 diabetes care discovered through electronic feedback led to increased nurse-GP cooperation. A qualitative study. Prim Care Diabetes. 2010 Apr;4(1):33-9. doi: 10.1016/j.pcd.2010.01.001. Epub 2010 Jan 21.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Torsten Lauritzen, MD, Dr. Med.

    Professor

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

November 5, 2009

First Posted

November 6, 2009

Study Start

March 1, 2007

Primary Completion

June 1, 2008

Study Completion

November 1, 2009

Last Updated

November 9, 2009

Record last verified: 2009-11

Locations